Roche expands the Global Access Program beyond HIV to also include diagnostic tests for Tuberculosis, Hepatitis, and Human Papillomavirus

    NEXT STORY
    Sandoz announces first patient enrolled in clinical study for proposed biosimilar denosumab in osteoporosis
    PREV STORY
    Two Decades Of Value Delivery And Partnership In Mali
    Subscribe to PM360
    Follow Us

    Experts on Call

    Get in touch with PM360 Experts On Call

    Ads

    You May Also Like

    Medigus Announces CMS’ Publication of Fee Schedules for Endoscopic Fundoplication Procedures Under CPT Code 43210 Effective January 2016

    OMER, Israel, Nov. 3, 2015 (GLOBE NEWSWIRE) -- Medigus Ltd. (NASDAQ:MDGS) (TASE:MDGS), a medical ...

    author_avatar
    NASDAQ Market News

    Global Rapid Microbiology Testing Market Will Reach USD 6,031 Million By 2025: Zion Market Research

    According to the report, the global rapid microbiology testing market accounted for USD 3,446 ...

    author_avatar
    NASDAQ Market News

    Press release Biocartis Group NV: LISTING OF THE EUR 150 MILLION SENIOR UNSECURED CONVERTIBLE BONDS DUE 9 MAY 2024

    author_avatar
    NASDAQ Market News